A CDC panel voted 11-1 in support of recommending Pfizer’s maternal RSV vaccine, Bloomberg reported.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
- Pfizer (NYSE:PFE) Slips as Paxlovid Proves Less Effective
- Alexion completes gene therapy purchase and license agreement from Pfizer
- GeoVax Labs publishes data from Phase 2 trial of next-gen COVID-19 vaccine
- GSK announces European Commission authorized ViiV Healthcare’s Apretude
- Pfizer announces EC approval for Litfulo